This presentation will cover Boehringer-Ingelheim’s thesis on quantum computing, our program composition, partners, and work completed so far. We will also discuss the potential applications of quantum computing in drug discovery and development, as well as the current limitations and future prospects of the technology. The presentation also highlights the need for collaboration between academia, industry, and government to fully harness the power of quantum computing in life science. Clemens Utschig-Utschig, CTO, Boehringer-Ingelheim